CTSS and cancer: Although tightly controlled under physiological conditions, the dysregulation and overactivation of cathepsins in the extracellular milieu are marked hallmarks of numerous diseases, such as inflammation and inflammation-associated diseases, various types of cancer, bone disorders, rheumatoid arthritis and cardiovascular diseases (35–37).